Navigation Links
InVitria's Cellastim Showcased in Nature Article
Date:10/7/2008

FORT COLLINS, Colo., Oct. 7 /PRNewswire/ -- A study published in the scientific journal Nature examining embryonic stem cell self-renewal, reported that InVitria's (http://www.InVitria.com) Cellastim (recombinant human serum albumin) was an effective replacement to bovine serum albumin in ES-cell culture.

The article entitled, "The ground state of embryonic stem cell self-renewal," disclosed that researchers used Cellastim as a recombinant albumin in place of animal-derived serum to eliminate contaminants in the cell culture. The Cellastim was a contributing factor in the enhancement of bulk passaging and clonal propagation (1).

"This study further supports the use of InVitria's Cellastim as an enhancement to cell culture media," said InVitria President Scott Deeter. "Cellastim is the only supplement available that not only improves cell culture performance, but does so while maintaining a defined and animal free media."

About InVitria (http://www.InVitria.com)

InVitria has developed cell culture ingredients that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, regenerative medicine, life science research and diagnostics industry. Cellastim is used to enhance cell growth and productivity. It is animal component free and has been used as a cell culture ingredient in regenerative medicine, mammalian cell culture media, stem cell media and primary cell media. (See http://www.Cellastim.com)

For more information about the InVitria line of products, please e-mail info@InVitria.com or call 1-800-916-8311.

(1) Ying, Q.L.et al. The ground state of embryonic stem cell self- renewal. Nature 453, 519-524 (May 2008).


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Brain Signature for Cigarette Cravings Identified
3. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
4. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
5. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
6. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
7. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
8. Tumor Eradication Article Published by Cancer Research
9. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
10. Clinical Trial Participation Unaffected by Disclosure of Investigators Financial Stake, Food and Drug Law Journal Article Finds
11. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Genomic Health, Inc. (Nasdaq: GHDX ) ... Onco type DX® breast cancer test, a multi-gene ... likelihood of chemotherapy benefit and recurrence risk for patients ... the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, ... TX. ,, "The breadth of data presented at last ...
(Date:12/15/2009)... Arlington Medical Resources (AMR) and Decision ... (MRSA) is the most concerning pathogen to surveyed ... treatment of skin and skin structure infections. A ... factors that influences European physician drug selection for ... factors that drive prescribing include an agent,s skin ...
(Date:12/15/2009)... INDIANAPOLIS, and CAMBRIDGE, Mass., Dec. 15 ... ), Eli Lilly and Company (NYSE: ... ) today announced positive results from a head-to-head ... therapy, to BYETTA® (exenatide) injection taken twice daily, ... weeks of treatment, patients taking exenatide once weekly ...
Breaking Medicine Technology:Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 2A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 2Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 4Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 5Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 6Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 7Study Forecasts More Young Doctors in Future 59852 1Study Forecasts More Young Doctors in Future 59852 2Experimental treatments restore partial vision to blind people 10444 1Experimental treatments restore partial vision to blind people 10444 2Minnesota Dentists Warn Halloween Shoppers 3A Sour Candies May Trick Not Treat Teeth 59846 1Minnesota Dentists Warn Halloween Shoppers 3A Sour Candies May Trick Not Treat Teeth 59846 2
... Drugs on the Market and, in Clinical Development with Each ... Anticancer Effects, and Expand the Markets for ... ... Identification of novel,cancer-related targets and pathways is redefining our understanding of ...
... Mich., Feb. 19 Compendia Bioscience, Inc.,today announced ... renewed,and expanding commitment from all major customers and ... to its customer roster. The new,customers and existing ... revenue increase, with similar growth forecasted for 2008., ...
Other Medicine Technology:Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 2Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 3Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 4On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 2On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 3
(Date:12/15/2009)... LocumTenens.com named 4th Best Staffing Firm to Work For. , ... ... Analysts has named LocumTenens.com, a leading provider of temporary physician and ... on their inaugural 2009 list., , , , ,“We are proud ... we care about investing in our associates,” said R. Shane Jackson ...
(Date:12/15/2009)... your trust as the most caring, conscientious practice you have ever ... the Dermatology Center of Dallas, we can help to achieve this ... ... (PRWEB) December 15, 2009 -- The Dermatology Center of Dallas, a ... arrival of Jeri Beth “J.B.” Foshee, MD in their practice. ...
(Date:12/15/2009)... of Spa, Massage, and Medical tables announces its partnership with ... comfort system to ease pressure felt while laying face down ... ... Pennsylvania (PRWEB) December 15, 2009 -- OAKWORKS®, Inc., the premier ... the launch of the Utopian Massage Table with patent pending ...
(Date:12/15/2009)... ... 2009 -- Millions of men and women suffer from spider veins ... or purple veins that spider-web across the nose, cheeks, legs and ankles. ... that 25-30% of women and 10-20% of men suffer from this unsightly ... been available for over 8 years in Europe (where it is enjoyed ...
(Date:12/15/2009)... Dec. 15 "The entire San Diego Hospice ... passing of Sol Price on December 14, 2009. Mr. ... integrity, loyalty and ethics in his business, community and ... humanitarian who truly understood the responsibility of philanthropy and ... legacy will live on through his countless philanthropic efforts. ...
Breaking Medicine News(10 mins):Health News:LocumTenens.com Named 4th Best Staffing Firm to Work For 2Health News:Jeri Beth “J.B.” Foshee, MD Joins Dermatology Center of Dallas 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4Health News:Vein Center & CosMed, Inc. Selected as Exclusive St. Louis Provider of FDA-Cleared Device 2Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2
... Men who have too much calcium in their bloodstreams ... according to a new analysis from Wake Forest University ... "We show that men in upper range of the ... three-fold increased risk for fatal prostate cancer," said Gary ...
... Foundation of Patient Driven Medicine, Note: September ... 2 Insurance,companies are denying Fibromyalgia patients proper ... are having a difficult time getting,their fibromyalgia patients ... the FDA fast tracked prescription medicine,Lyrica and now ...
... Fla., Sept. 2 MBF Healthcare,Acquisition Corp. ... special purpose,acquisition company, announced today the amendment ... acquisition of Critical Homecare Solutions,Holdings, Inc. ("CHS"), ... dated February 6, 2008 (the "Stock Purchase ...
... Cogdell Spencer Inc.,(NYSE: CSA ) announces the ... million medical office building and outpatient treatment center ... is the first synergy project since the,closing of ... Erdman, A,Cogdell Spencer Company). The project will include ...
... eat unhealthy foods, study suggests , , TUESDAY, Sept. ... who pick up the stress of their anxious mothers ... their risk of becoming overweight, a new study says. ... secure, meaning they have access to a sufficient amount ...
... Cole, Leona Lewis, Mariah, Carey, Mary J. Blige, Miley Cyrus, Rihanna, Natasha ... ... Sept 2 Conde Nast Media Group announced today,that Ashanti, Carrie Underwood, ... Rihanna, Natasha Bedingfield, and,Sheryl Crow will join together on stage at Radio ...
Other Medicine News:Health News:Too much calcium in blood may increase risk of fatal prostate cancer 2Health News:Too much calcium in blood may increase risk of fatal prostate cancer 3Health News:Important Information on Fibromyalgia and Access to Treatments 2Health News:Important Information on Fibromyalgia and Access to Treatments 3Health News:MBF Healthcare Acquisition Corp. Amends Stock Purchase Agreement With Critical Homecare Solutions Holdings, Inc. to Extend Termination Date to October 31, 2008 2Health News:MBF Healthcare Acquisition Corp. Amends Stock Purchase Agreement With Critical Homecare Solutions Holdings, Inc. to Extend Termination Date to October 31, 2008 3Health News:MBF Healthcare Acquisition Corp. Amends Stock Purchase Agreement With Critical Homecare Solutions Holdings, Inc. to Extend Termination Date to October 31, 2008 4Health News:Cogdell Spencer Announces First Synergy Project in Pensacola, Florida 2Health News:Cogdell Spencer Announces First Synergy Project in Pensacola, Florida 3Health News:Kids of Stressed, Low-Income Moms Prone to Weight Problems 2Health News:Kids of Stressed, Low-Income Moms Prone to Weight Problems 3Health News:Conde Nast Media Group Announces Performance of 'Just Stand Up' to be Fed Live from the Stage at FASHION ROCKS to ABC, CBS and NBC's Simultaneous Broadcast of Stand Up To Cancer Nationwide Fund-Raising Event On September 5th 2Health News:Conde Nast Media Group Announces Performance of 'Just Stand Up' to be Fed Live from the Stage at FASHION ROCKS to ABC, CBS and NBC's Simultaneous Broadcast of Stand Up To Cancer Nationwide Fund-Raising Event On September 5th 3
For the quantitative determination of uric acid in serum....
... new level of immunodiagnostic productivity. Optimal flexibility. ... laboratory automation system. No-pause loading of all ... only immunoassay system with this capability. No ... without any additional setup. Continuous sample loading. ...
... Engineered for continuous, random access operation, the ... medium to large volume laboratories that want ... offers the simplicity, flexibility and Stat capabilities ... can be adapted to the changing needs ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
Medicine Products: